Home / Going-concern warnings / STRATA Skin Sciences, Inc.
Filed 2025-11-14 路 Form 10-Q 路 Accession 0001140361-25-042373 nano
Price before filing: $1.52 (2025-11-13 close, split/dividend-adjusted)
Market cap at flag: $8.0M (2025-11-14) 路 Latest: $1,178 (2026-10-15)
| Window | SSKN | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -10.5% | +1.3% | -11.8% | 2025-12-15 |
| 90 days | -74.3% | +1.7% | -76.0% | 2026-02-12 |
| 180 days | -89.5% | +11.1% | -100.6% | 2026-05-13 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: no open-market insider sales or purchases reported.
30 days after: 1 insider sold $19K (3 sales); 1 insider bought $7K (2 purchases)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2025-11-14: red flag filed | |||||||
| 2025-11-17 | Rubinstein Samuel Director | Sale | 5,500 | $1.32 | $7K | no | Form 4 |
| 2025-11-17 | Rubinstein Samuel Director | Sale | 7,200 | $1.34 | $10K | no | Form 4 |
| 2025-11-17 | Rubinstein Samuel Director | Sale | 1,394 | $1.36 | $2K | no | Form 4 |
| 2025-11-18 | Rubinstein Samuel Director | Purchase | 2,168 | $1.40 | $3K | no | Form 4 |
| 2025-11-18 | Rubinstein Samuel Director | Purchase | 2,832 | $1.41 | $4K | no | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-08-16 to 2025-12-14. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"Note 2 Liquidity: The Company has historically experienced recurring losses and negative working capital and has been dependent on raising capital from the sale of securities in order to continue to operate, which raises substantial doubt regarding the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-09-30)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.